Status:
COMPLETED
State of the Art Photon Therapy Versus Particle Therapy for Recurrent Head & Neck Tumors; a Planning Study
Lead Sponsor:
Maastricht Radiation Oncology
Collaborating Sponsors:
University of Pennsylvania
Philipps University Marburg
Conditions:
Carcinoma, Squamous Cell of Head and Neck
Eligibility:
All Genders
18+ years
Brief Summary
Given that the cost of proton therapy is considerably higher than that of conventional radiotherapy with photons, it is necessary to establish whether these higher costs are worthwhile in light of the...
Detailed Description
The CTV to PTV margin will be determined by the individual institutes according to the treatment technique and treatment modality. For all treatment plans, modified ICRU 50 will be applied. The ICRU 5...
Eligibility Criteria
Inclusion
- Primary treatment:
- ≥ 50 Gy with curative intent (with or without chemo)
- CTV includes primary tumor and at least level II-IV
- Severe dental scatter artifacts or metal implants of unknown density will be excluded
- IMRT plan available
- Secondary treatment after ≥ 1 year, dose 70 Gy
- a. Severe dental scatter artifacts or metal implants of unknown density will be excluded
- Overlap of at least one OAR in primary and secondary treatment
Exclusion
- Patients referred for postoperative radiotherapy
Key Trial Info
Start Date :
May 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT02242916
Start Date
May 1 2014
End Date
October 1 2015
Last Update
January 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastro Clinic
Maastricht, Netherlands, 6229 ET